What are 5-HTP’s main benefits?

    Last Updated: June 12, 2024

    5-HTP is very reliable for increasing serotonin levels in presynaptic neurons in the brain and is actually used as a test drug to help determine the potency of other serotonin-increasing substances.[1]

    Most of the research has looked at 5-HTP for its potential role in treating depression. This is based on the serotonin theory of depression — the debatable theory that depression is the result of low serotonin in the brain.[2] While some research has been promising, the body of evidence is weak overall. Most of this research was conducted in the 1970s and 1980s with poor methodological quality.[3][4]

    5-HTP may reduce symptoms of depression compared to a placebo when taken alone or in addition to standard treatment.[3] Also, two short-term studies (6 to 8 weeks) reported that 5-HTP reduced symptoms of depression to a similar degree as the SSRI antidepressant medications fluoxetine and fluvoxamine.[5][6] While this is promising, higher quality research is needed to confirm these effects.

    5-HTP may also play a role in appetite regulation. In people with overweight or obesity, researchers have observed weight loss due to reduced calorie intake and increased satiety, or the feeling of fullness, during supplementation with 5-HTP.[7][8][9]

    5-HTP has also been studied for its effects on migraine or tension headache prevention,[10][11][12] fibromyalgia,[13][14] and Parkinson’s disease.[15][16] Currently, research is mixed and largely inconclusive.

    References

    1. ^O'Neil MF, Moore NAAnimal models of depression: are there any?Hum Psychopharmacol.(2003 Jun)
    2. ^Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MAThe serotonin theory of depression: a systematic umbrella review of the evidence.Mol Psychiatry.(2023-Aug)
    3. ^Erick H Turner, Jennifer M Loftis, Aaron D BlackwellSerotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophanPharmacol Ther.(2006 Mar)
    4. ^Shaw K, Turner J, Del Mar CAre tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis.Aust N Z J Psychiatry.(2002 Aug)
    5. ^Jangid P, Malik P, Singh P, Sharma M, Gulia AKComparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode.Asian J Psychiatr.(2013-Feb)
    6. ^Pöldinger W, Calanchini B, Schwarz WA functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine.Psychopathology.(1991)
    7. ^Cangiano C, Laviano A, Del Ben M, Preziosa I, Angelico F, Cascino A, Rossi-Fanelli FEffects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patientsInt J Obes Relat Metab Disord.(1998 Jul)
    8. ^Cangiano C, Ceci F, Cascino A, Del Ben M, Laviano A, Muscaritoli M, Antonucci F, Rossi-Fanelli FEating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophanAm J Clin Nutr.(1992 Nov)
    9. ^Ceci F, Cangiano C, Cairella M, Cascino A, Del Ben M, Muscaritoli M, Sibilia L, Rossi Fanelli FThe effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjectsJ Neural Transm.(1989)
    10. ^Ribeiro CAL-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society.Headache.(2000 Jun)
    11. ^De Benedittis G, Massei RSerotonin precursors in chronic primary headache. A double-blind cross-over study with L-5-hydroxytryptophan vs. placebo.J Neurosurg Sci.(1985 Jul-Sep)
    12. ^Titus F, Dávalos A, Alom J, Codina A5-Hydroxytryptophan versus methysergide in the prophylaxis of migraine. Randomized clinical trial.Eur Neurol.(1986)
    13. ^Caruso I, Sarzi Puttini P, Cazzola M, Azzolini VDouble-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome.J Int Med Res.(1990 May-Jun)
    14. ^Sarzi Puttini P, Caruso IPrimary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study.J Int Med Res.(1992 Apr)
    15. ^Meloni M, Puligheddu M, Sanna F, Cannas A, Farris R, Tronci E, Figorilli M, Defazio G, Carta MEfficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding.J Neurol Sci.(2020 Aug 15)
    16. ^Chase TN, Ng LK, Watanabe AMParkinson's disease. Modification by 5-hydroxytryptophan.Neurology.(1972 May)